| Marissa Dalio, | |
|
3767 Delaware Ave, Kenmore, NY 14217-1040 | |
| (716) 874-6175 | |
| Not Available |
| Full Name | Marissa Dalio |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist - Pediatrics |
| Location | 3767 Delaware Ave, Kenmore, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023796539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251P0200X | Physical Therapist - Pediatrics | (* (Not Available)) | Secondary |
| 2251P0200X | Physical Therapist - Pediatrics | 051153 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marissa Dalio, 355 Harlem Rd, West Seneca, NY 14224-1825 Ph: () - | Marissa Dalio, 3767 Delaware Ave, Kenmore, NY 14217-1040 Ph: (716) 874-6175 |
News Archive
Chronic obstructive pulmonary disease patients should be monitored for the onset of arrhythmia when they begin bronchodilator therapy, say the authors of a Canadian study.
Researchers at the University of California, Riverside have discovered the world's strongest acid. Remarkably it is also the gentlest acid. This non-toxic and non-corrosive acid may have a role in processes such as improving the quality of gasoline, developing polymers and synthesizing pharmaceuticals.
Adults with lupus who report having had adverse childhood experiences, such as abuse, neglect and household challenges, report higher disease activity, depression and poorer overall health compared to those without such experiences, according to a study by researchers at UC San Francisco.
Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.
Ashkenazi Jewish women are known to have a predisposition to the inherited breast cancers BRCA1 and BRCA2, but currently genetic testing in this group is limited to women affected by breast and ovarian cancers and those who are unaffected but have a family history of the disease.
› Verified 2 days ago
Sharon Karnyski, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Delaware Avenu, Kenmore, NY 14217 Phone: 716-871-9883 Fax: 716-871-9887 | |
Megan Overlan, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3767 Delaware Ave, Kenmore, NY 14217 Phone: 716-874-6175 | |
Amanda Schoenthal-martin, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3767 Delaware Ave, Kenmore, NY 14217 Phone: 716-874-6175 | |
Shannon Wrona, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3767 Delaware Ave, Kenmore, NY 14217 Phone: 716-874-6175 | |
Sarah Kociszewski, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Delaware Ave, Kenmore, NY 14217 Phone: 716-871-9883 | |
Christine Woodrick, PT DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2760 Delaware Ave, Kenmore, NY 14217 Phone: 716-423-2262 Fax: 716-423-2263 |